Search Results - R Della Pepa
- Showing 1 - 10 results of 10
-
1
-
2
-
3
P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA by R Iula, F Trastulli, R Della Pepa, A D’Ambrosio, M Romano, A Leone, G Gaeta, S Palmieri, S Rocco, F Pane, F Ferrara, L Catalano
Published in HemaSphere (2022-04-01)Get full text
Article -
4
P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38... by M. Offidani, S. Morè, M. Cavo, D. Derudas, F. Di Raimondo, A. Cuneo, L. Baldini, R. Della Pepa, M. Musso, M. Boccadoro, P. Musto, A. Belotti, F. Fioritoni, N. Di Renzo, A. Mele, B. Gamberi, L. De Paoli, R. Zambello, S. Grammatico, M. Brociner, F. Fazio, M. T. Petrucci
Published in HemaSphere (2023-05-01)Get full text
Article -
5
P174 | EFFICACY AND SAFETY OF ISATUXIMAB, CARFILZOMIB AND DEXAME-THASONE (ISAKD) IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION AND LENALI... by N. Sgherza, P. Curci, O. Battisti, C. Conticello, S. Palmieri, D. Derudas, C. Germano, E.A. Martino, G. Mele, R. Della Pepa, F. Fazio, A. Mele, B. Rossini, G. Palazzo, D. Roccotelli, S. Rasola, M.T. Petrucci, D. Pastore, G. Tarantini, F. Pane, M. Gentile, F. Di Raimondo, E. Resta, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
6
P158 | DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED ≥80 YEARS: A MULTICENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND TOLERABILITY FR... by S. Palmieri, R. Della Pepa, S. Rocco, D. De Novellis, G. Marcacci, G. Cetani, V. Amico, M. Barone, R. Bianco, D. Esposito, M. Raimondo, A. Leone, M. Fevola, N. Pugliese, R. Fontana, M. Rizzo, M. Bonanni, M. Arcamone, C. Masucci, G.R. Nunziata, A.M. Risitano, C. Califano, G. Cerciello, F. Frigeri, A. Pinto, C. Selleri, F. Pane
Published in Haematologica (2025-09-01)Get full text
Article -
7
DP117 | THE TREATMENT OF TRANSPLANT ELIGIBLE PRIMARY PLASMA CELL LEUKEMIA PATIENTS: AN ITALIAN REAL-LIFE STUDY by G. Barilà, L. Pavan, F. Fazio, C. Liberatore, N. Sgherza, S. Morè, G. Vianello, C. S. Cartia, S. Oliva, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, L. Pettine, B. Rossini, F. Guidotti, S. Vedovato, F. Rezzonico, R. Della Pepa, P. Boggione, D. Derudas, D. Nappi, F. Farina, F. Vassallo, B. Gamberi, S. Mangiacavalli, N. Giuliani, M. Galli, A. Tosetto, E. Zamagni, F. Patriarca, M. Offidani, M. T. Petrucci, R. Zambello, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
8
P167 | OUTCOMES OF SECOND-LINE THERAPY IN FUNCTIONAL HIGH-RISK MULTIPLE MYELOMA AFTER DARATUMUMAB-BASED INDUCTION: AN ITALIAN REAL-WORLD STUDY by S. Palmieri, S. Rocco, R. Della Pepa, D. Derudas, D. Roccotelli, D. Esposito, C. Masucci, E. Gigliotta, M.L. Barone, E. Morelli, A. Lazzaro, G. Cetani, F. Accardi, M. Bonanni, A.M. Della Corte, B. Serio, E. Urciuoli, R. Bianco, M. Rizzo, R. Fontana, M. Arcamone, R. Iula, A. Dandolo, A. Leone, M.G. Rascato, M. Di Perna, A.P. Falcone, L. Morello, G. Marcacci, G.R. Nunziata, F. Frigeri, C. Califano, A.M. Carella, A.M. Risitano, M. Annunziata, F. Pane, C. Botta
Published in Haematologica (2025-09-01)Get full text
Article -
9
C063 | ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE VERSUS DARATUMUMAB-POMALIDOMIDE-DEXAMETHASONE IN PATIENTS PROGRESSING AFTER LENALIDOMIDE MAINTENANCE: AN ITALIAN REAL-LIFE STUDY by V. Ruocco, C. Liberatore, E. Olivari, M. Tinelli, F. Fazio, E. Favero, C.S. Cartia, N. Sgherza, C. Conticello, R. Mina, M. Gherardini, G. Mele, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, B. Rossini, E. Scomazzon, F. Monaco, E.A. Martino, C. De Magistris, F. Fioritoni, A.M. Cafro, S. Pezzatti, R. Della Pepa, P. Boggione, G. Pietrantuono, V. Tomarchio, F. Vassallo, M.L. Pioltelli, F. Pisani, A. Cagnetta, G. Buda, E. Antonioli, L. Paris, A. Tosetto, P. Musto, E. Zamagni, F. Patriarca, S. Mangiacavalli, R. Zambello, M. Offidani
Published in Haematologica (2025-09-01)Get full text
Article -
10
P173 | CLINICAL EFFICACY OF ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2025 DATA UPDATE by D. Derudas, D. Vincelli, R. Fontana, R. Della Pepa, S. Palmieri, F. Accardi, F. Rotondo, E. Morelli, E. Gigliotta, D. Roccotelli, L. Marano, M.l. Barone, G. Cetani, D. Esposito, A. Lazzaro, G. Delle Cave, B. Serio, D. Morini, M. Porrazzo, E. Urciuoli, C. Masucci, F. Fanelli, M. Rizzo, M. Arcamone, F. Trastulli, S. Rocco, A. Leone, R. Bianco, F. Salvatore, A. Idato, M. Sicari, P. Tosi, M.G. Rascato, M. Di Perna, A.P. Falcone, L. Morello, M. Carlisi, G. Svanera, G.R. Nunziata, M. Annunziata, F. Frigeri, C. Califano, A.M. Carella, G. Marcacci, F. Pane, A.M. Risitano, C. Botta
Published in Haematologica (2025-09-01)Get full text
Article
